Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

JWJ Esser, HGM Niesters, Ronnie van der Holt, E Meijer, Ab Osterhaus, JW (S.) Gratama, LF Verdonck, Bob Löwenberg, Jan Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

334 Citations (Scopus)
6 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)4364-4369
Number of pages6
Issue number12
Publication statusPublished - 2002

Cite this